Karin Göhlin

Karin Göhlin has over two decades of experience in project and portfolio management in the pharmaceutical industry. Karin is currently serving as Vice President Project Management at Calliditas Therapeutics AB since March 2021. Prior to their current role, Karin was the Chief Project Officer at Lantmännen from August 2019 to March 2021. Karin also worked as the Director of Project and Portfolio Management at Medivir AB from 2012 to July 2019. Karin's previous roles include VP Alliance Management at Orexo AB from 2008 to 2012, VP Project Management at Biolipox from 2004 to 2008, and Global Project Manager and Pharmaceutical Project Manager at AstraZeneca R&D from 1994 to 2004.

Karin Göhlin obtained their Doctor of Philosophy (Ph.D.) degree in Analytical Chemistry from the University of Gothenburg between 1988 and 1993. Prior to that, they attended Sundstagymnasiet, although specific information regarding the duration and field of study during this time period is not available.